TR200403020T2 - (S)-4-Amino-5-kloro-2-metoksi-N- (1-(1-(2-tetrahidrofuril-carbonil)-4-piperidinylmetil) -4-piperidinil)benzamit, bunun hazırlama işlemi ve aynı formülü ve bunun ara mamülünü içeren farmasötik bileşim - Google Patents
(S)-4-Amino-5-kloro-2-metoksi-N- (1-(1-(2-tetrahidrofuril-carbonil)-4-piperidinylmetil) -4-piperidinil)benzamit, bunun hazırlama işlemi ve aynı formülü ve bunun ara mamülünü içeren farmasötik bileşimInfo
- Publication number
- TR200403020T2 TR200403020T2 TR2004/03020T TR200403020T TR200403020T2 TR 200403020 T2 TR200403020 T2 TR 200403020T2 TR 2004/03020 T TR2004/03020 T TR 2004/03020T TR 200403020 T TR200403020 T TR 200403020T TR 200403020 T2 TR200403020 T2 TR 200403020T2
- Authority
- TR
- Turkey
- Prior art keywords
- tetrahydrofurylcarbonyl
- piperidinylmethyl
- benzamide
- piperidinyl
- chloro
- Prior art date
Links
- MMAHZLJRNLZQCI-NRFANRHFSA-N 4-amino-5-chloro-2-methoxy-n-[1-[[1-[(2s)-oxolane-2-carbonyl]piperidin-4-yl]methyl]piperidin-4-yl]benzamide Chemical compound COC1=CC(N)=C(Cl)C=C1C(=O)NC1CCN(CC2CCN(CC2)C(=O)[C@H]2OCCC2)CC1 MMAHZLJRNLZQCI-NRFANRHFSA-N 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 108091005482 5-HT4 receptors Proteins 0.000 abstract 2
- 230000005176 gastrointestinal motility Effects 0.000 abstract 2
- 230000003389 potentiating effect Effects 0.000 abstract 2
- -1 N- [1- [1- (2-tetrahydrofurylcarbonyl) -4-piperidinylmethyl] -4-piperidinyl] benzamide Chemical compound 0.000 abstract 1
- 230000001270 agonistic effect Effects 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nutrition Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2002141262 | 2002-05-16 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TR200403020T2 true TR200403020T2 (tr) | 2005-05-23 |
Family
ID=29267809
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TR2004/03020T TR200403020T2 (tr) | 2002-05-16 | 2003-05-15 | (S)-4-Amino-5-kloro-2-metoksi-N- (1-(1-(2-tetrahidrofuril-carbonil)-4-piperidinylmetil) -4-piperidinil)benzamit, bunun hazırlama işlemi ve aynı formülü ve bunun ara mamülünü içeren farmasötik bileşim |
Country Status (26)
| Country | Link |
|---|---|
| US (1) | US6696468B2 (https=) |
| EP (1) | EP1362857B1 (https=) |
| JP (1) | JP3643107B2 (https=) |
| KR (1) | KR20040107520A (https=) |
| CN (1) | CN1653063A (https=) |
| AR (1) | AR040021A1 (https=) |
| AT (1) | ATE273304T1 (https=) |
| AU (1) | AU2003230245A1 (https=) |
| BR (1) | BR0309933A (https=) |
| CA (1) | CA2483368A1 (https=) |
| CZ (1) | CZ20041084A3 (https=) |
| DE (1) | DE60300021T2 (https=) |
| DK (1) | DK1362857T3 (https=) |
| ES (1) | ES2227500T3 (https=) |
| HU (1) | HUP0501016A2 (https=) |
| IL (1) | IL165012A0 (https=) |
| MX (1) | MXPA04011332A (https=) |
| NO (1) | NO20045469L (https=) |
| PL (1) | PL372724A1 (https=) |
| PT (1) | PT1362857E (https=) |
| RU (1) | RU2004136853A (https=) |
| SK (1) | SK50192004A3 (https=) |
| TR (1) | TR200403020T2 (https=) |
| TW (1) | TW200400186A (https=) |
| WO (1) | WO2003097638A1 (https=) |
| ZA (1) | ZA200409053B (https=) |
Families Citing this family (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE9904377D0 (sv) * | 1999-12-01 | 1999-12-01 | Astra Pharma Prod | Pharmaceutical combinations |
| SE0200844D0 (sv) | 2002-03-19 | 2002-03-19 | Astrazeneca Ab | Chemical compounds |
| SE0200843D0 (sv) | 2002-03-19 | 2002-03-19 | Astrazeneca Ab | Chemical compounds |
| SE0300957D0 (sv) | 2003-04-01 | 2003-04-01 | Astrazeneca Ab | Chemical compounds |
| TW200533348A (en) * | 2004-02-18 | 2005-10-16 | Theravance Inc | Indazole-carboxamide compounds as 5-ht4 receptor agonists |
| TWI351282B (en) | 2004-04-07 | 2011-11-01 | Theravance Inc | Quinolinone-carboxamide compounds as 5-ht4 recepto |
| US7728006B2 (en) * | 2004-04-07 | 2010-06-01 | Theravance, Inc. | Quinolinone-carboxamide compounds as 5-HT4 receptor agonists |
| US8309575B2 (en) | 2004-04-07 | 2012-11-13 | Theravance, Inc. | Quinolinone-carboxamide compounds as 5-HT4 receptor agonists |
| US7399862B2 (en) * | 2004-11-05 | 2008-07-15 | Theravance, Inc. | 5-HT4 receptor agonist compounds |
| WO2006052889A2 (en) * | 2004-11-05 | 2006-05-18 | Theravance, Inc. | Quinolinone-carboxamide compounds |
| CA2588037A1 (en) * | 2004-12-22 | 2006-06-29 | Theravance, Inc. | Indazole-carboxamide compounds |
| CN101163701A (zh) * | 2005-03-02 | 2008-04-16 | 施万制药 | 作为5-ht4受体激动剂的喹啉酮化合物 |
| US7256294B2 (en) * | 2005-05-25 | 2007-08-14 | Theravance, Inc. | Crystalline form of a benzimidazole-carboxamide medicinal compound |
| MY147756A (en) | 2005-05-25 | 2013-01-15 | Theravance Inc | Benzimidazole-carboxamide compounds as 5-ht4 receptor agonists |
| TW200722419A (en) * | 2005-05-27 | 2007-06-16 | Astrazeneca Ab | Chemical compounds |
| US20080200505A1 (en) * | 2005-05-27 | 2008-08-21 | Astrazeneca Ab | Piperidines for the Treatment of Chemokine Mediated Diseases |
| WO2007011293A1 (en) | 2005-07-21 | 2007-01-25 | Astrazeneca Ab | Novel piperidine derivatives |
| GB0525068D0 (en) | 2005-12-08 | 2006-01-18 | Novartis Ag | Organic compounds |
| TWI423967B (zh) * | 2008-02-21 | 2014-01-21 | Dainippon Sumitomo Pharma Co | 醯胺衍生物及含有其之醫藥組合物 |
| US8349852B2 (en) | 2009-01-13 | 2013-01-08 | Novartis Ag | Quinazolinone derivatives useful as vanilloid antagonists |
| WO2011092290A1 (en) | 2010-02-01 | 2011-08-04 | Novartis Ag | Pyrazolo[5,1b]oxazole derivatives as crf-1 receptor antagonists |
| AR080056A1 (es) | 2010-02-01 | 2012-03-07 | Novartis Ag | Derivados de ciclohexil-amida como antagonistas de los receptores de crf |
| EP2531490B1 (en) | 2010-02-02 | 2014-10-15 | Novartis AG | Cyclohexyl amide derivatives as crf receptor antagonists |
| AR086554A1 (es) | 2011-05-27 | 2014-01-08 | Novartis Ag | Derivados de la piperidina 3-espirociclica como agonistas de receptores de la ghrelina |
| JP2015525202A (ja) | 2012-05-03 | 2015-09-03 | ノバルティス アーゲー | グレリン受容体アゴニストとしての２，７−ジアザ−スピロ［４，５］デカ−７−イル誘導体のｌ−リンゴ酸塩およびその結晶形態 |
| IL297456A (en) * | 2020-05-04 | 2022-12-01 | Takeda Pharmaceuticals Co | n-(piperidin-4-yl)benzamide derivatives are active in Nahor |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH111472A (ja) | 1996-04-30 | 1999-01-06 | Dainippon Pharmaceut Co Ltd | ベンズアミド誘導体及びそれを含有する医薬組成物 |
| EP1076055B1 (en) * | 1998-04-28 | 2004-11-24 | Dainippon Pharmaceutical Co., Ltd. | 1- (1-substituted-4-piperidinyl)methyl]-4-piperidine derivatives, process for producing the same, medicinal compositions containing the same and intermediates of these compounds |
| JP2000080081A (ja) | 1998-06-24 | 2000-03-21 | Dainippon Pharmaceut Co Ltd | １―〔（１―置換―４―ピペリジニル）メチル〕―４―ピペリジン誘導体及びそれを含有する医薬組成物 |
| JP2001122784A (ja) | 1999-10-27 | 2001-05-08 | Dainippon Pharmaceut Co Ltd | １−［（１−置換−４−ピペリジニル）メチル］−４−ピペリジン誘導体からなる医薬 |
-
2002
- 2002-12-18 US US10/321,615 patent/US6696468B2/en not_active Expired - Fee Related
-
2003
- 2003-01-03 ES ES03250050T patent/ES2227500T3/es not_active Expired - Lifetime
- 2003-01-03 EP EP03250050A patent/EP1362857B1/en not_active Expired - Lifetime
- 2003-01-03 DE DE60300021T patent/DE60300021T2/de not_active Expired - Fee Related
- 2003-01-03 AT AT03250050T patent/ATE273304T1/de not_active IP Right Cessation
- 2003-01-03 PT PT03250050T patent/PT1362857E/pt unknown
- 2003-01-03 DK DK03250050T patent/DK1362857T3/da active
- 2003-05-08 TW TW092112525A patent/TW200400186A/zh unknown
- 2003-05-15 AU AU2003230245A patent/AU2003230245A1/en not_active Abandoned
- 2003-05-15 CN CNA03811089XA patent/CN1653063A/zh active Pending
- 2003-05-15 AR ARP030101702A patent/AR040021A1/es unknown
- 2003-05-15 WO PCT/JP2003/006051 patent/WO2003097638A1/en not_active Ceased
- 2003-05-15 MX MXPA04011332A patent/MXPA04011332A/es unknown
- 2003-05-15 RU RU2004136853/04A patent/RU2004136853A/ru not_active Application Discontinuation
- 2003-05-15 BR BR0309933-4A patent/BR0309933A/pt not_active Application Discontinuation
- 2003-05-15 KR KR10-2004-7018158A patent/KR20040107520A/ko not_active Withdrawn
- 2003-05-15 TR TR2004/03020T patent/TR200403020T2/xx unknown
- 2003-05-15 HU HU0501016A patent/HUP0501016A2/hu unknown
- 2003-05-15 PL PL03372724A patent/PL372724A1/xx not_active Application Discontinuation
- 2003-05-15 SK SK5019-2004A patent/SK50192004A3/sk unknown
- 2003-05-15 CA CA002483368A patent/CA2483368A1/en not_active Abandoned
- 2003-05-15 JP JP2003137413A patent/JP3643107B2/ja not_active Expired - Fee Related
- 2003-05-15 CZ CZ20041084A patent/CZ20041084A3/cs unknown
- 2003-05-15 IL IL16501203A patent/IL165012A0/xx unknown
-
2004
- 2004-11-09 ZA ZA200409035A patent/ZA200409053B/en unknown
- 2004-12-15 NO NO20045469A patent/NO20045469L/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| PL372724A1 (en) | 2005-07-25 |
| HK1060118A1 (en) | 2004-07-30 |
| HUP0501016A2 (en) | 2006-02-28 |
| ZA200409053B (en) | 2005-07-12 |
| KR20040107520A (ko) | 2004-12-20 |
| US20030216433A1 (en) | 2003-11-20 |
| DE60300021D1 (de) | 2004-09-16 |
| EP1362857A1 (en) | 2003-11-19 |
| US6696468B2 (en) | 2004-02-24 |
| BR0309933A (pt) | 2005-02-09 |
| AR040021A1 (es) | 2005-03-09 |
| DK1362857T3 (da) | 2004-12-20 |
| AU2003230245A1 (en) | 2003-12-02 |
| SK50192004A3 (sk) | 2005-04-01 |
| ES2227500T3 (es) | 2005-04-01 |
| IL165012A0 (en) | 2005-12-18 |
| EP1362857B1 (en) | 2004-08-11 |
| MXPA04011332A (es) | 2005-02-14 |
| ATE273304T1 (de) | 2004-08-15 |
| CZ20041084A3 (cs) | 2005-02-16 |
| JP3643107B2 (ja) | 2005-04-27 |
| WO2003097638A1 (en) | 2003-11-27 |
| CN1653063A (zh) | 2005-08-10 |
| CA2483368A1 (en) | 2003-11-27 |
| JP2004043453A (ja) | 2004-02-12 |
| DE60300021T2 (de) | 2005-09-08 |
| TW200400186A (en) | 2004-01-01 |
| RU2004136853A (ru) | 2005-06-27 |
| NO20045469L (no) | 2005-02-16 |
| PT1362857E (pt) | 2004-11-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TR200403020T2 (tr) | (S)-4-Amino-5-kloro-2-metoksi-N- (1-(1-(2-tetrahidrofuril-carbonil)-4-piperidinylmetil) -4-piperidinil)benzamit, bunun hazırlama işlemi ve aynı formülü ve bunun ara mamülünü içeren farmasötik bileşim | |
| EA200301073A1 (ru) | N-(2-арилэтил)бензиламины в качестве антагонистов 5-ht-рецептора | |
| NO20071108L (no) | Nye 4-benzylidenpiperidinderivater | |
| GEP20074197B (en) | 5ht2c receptor modulators | |
| TR200504337T1 (tr) | Imatinib mezilat'ın yeni polimorfları | |
| GB0115862D0 (en) | Compounds | |
| MXPA04000707A (es) | Nuevos antagonistas del receptor y5 del neuropeptido y referencia cruzada a solicitudes relacionadas. | |
| DK2021336T3 (da) | 11-beta-hydroxysteroid-dehydrogenase-1-inhibitorer | |
| DK1651615T3 (da) | Pyridazinyl-piperaziner og anvendelse deraf som histamin-H3-receptorligander | |
| JO2515B1 (en) | Gamma-Crystalline form of ivabradine hydrochloride,a process for its preparation and pharmaceutical composition containing it | |
| TW200745031A (en) | Acyl indoles, compositions containing such compounds and methods of use | |
| DE69725345D1 (de) | Verwendung von 5-ht4 antagonisten zur überwindung der gastrointestinalen beschädigung, die durch inhibitoren der serotonin-wiederaufnahme hervorgerufen werden | |
| AR028817A1 (es) | Compuestos derivados de la 1-arenosulfonil-2-arilo-pirrolidina, su empleo, un procedimiento para obtenerlos y medicamentos que los contienen | |
| WO2004005262A8 (en) | New neuropeptide y y5 receptor antagonists | |
| ATE334965T1 (de) | Piperidinverbindungen als muscarinantagonisten | |
| CO5460266A1 (es) | Novedosos analogos de la somatostatina | |
| TW200800946A (en) | Substituted piperazines as metabotropic glutamate receptor antagonists | |
| AR026209A1 (es) | Compuestos monociclicos basicos con accion nk-2 antagonista, procesos de fabricacion y formulas que los contienen | |
| BRPI0409511A (pt) | composto, composição farmacêutica, e, uso do composto | |
| IL182298A0 (en) | 4-hydroxy tamoxifen gel formulations | |
| DE602004029462D1 (de) | Isochinolin-3-carbonsäureamide und ihre pharmazeutische verwendung | |
| AU2003262926A1 (en) | Selective d1/d5 receptor antagonists for the treatment of obesity and cns disorders | |
| SE0303419D0 (sv) | New use 11 | |
| SE0303488D0 (sv) | New use 1X | |
| DK1668027T3 (da) | Cykliske peptider, der virker som urotensin-II antagonister |